His work on Microbiology as part of general Antibiotics study is frequently linked to Gynecology, therefore connecting diverse disciplines of science. Microbiology is closely attributed to Cefpodoxime in his work. His study on Cefpodoxime is mostly dedicated to connecting different topics, such as Antibacterial agent. The study of Antibacterial agent is intertwined with the study of Antibiotics in a number of ways. Many of his studies on Pathology involve topics that are commonly interrelated, such as Clinical endpoint. Alberto S. Pappo combines topics linked to Surgery with his work on Clinical endpoint. Alberto S. Pappo integrates many fields, such as Surgery and Internal medicine, in his works. Alberto S. Pappo performs multidisciplinary studies into Internal medicine and Gastroenterology in his work. Alberto S. Pappo conducts interdisciplinary study in the fields of Gastroenterology and Pathology through his works.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
Alexander Drilon;Theodore W. Laetsch;Shivaani Kummar;Steven G. DuBois.
The New England Journal of Medicine (2018)
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.
George D. Demetri;Robert S. Benjamin;Charles D. Blanke;Jean Yves Blay.
Journal of The National Comprehensive Cancer Network (2007)
Germline Mutations in Predisposition Genes in Pediatric Cancer
Jinghui Zhang;Michael F. Walsh;Gang Wu;Michael N. Edmonson.
The New England Journal of Medicine (2015)
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology
Margaret von Mehren;R. Lor Randall;Robert S. Benjamin;Sarah Boles.
Journal of The National Comprehensive Cancer Network (2016)
Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Xiang Chen;Armita Bahrami;Alberto Pappo;John Easton.
Cell Reports (2014)
Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
R. Raney;James Anderson;Frederic Barr;Sarah Donaldson.
Journal of Pediatric Hematology Oncology (2001)
Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV
John C. Breneman;Elizabeth Lyden;Alberto S. Pappo;Michael P. Link.
Journal of Clinical Oncology (2003)
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
David S Hong;Steven G DuBois;Shivaani Kummar;Anna F Farago.
Lancet Oncology (2020)
Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
Nai-Kong V. Cheung;Jinghui Zhang;Charles Lu;Matthew Parker.
R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study
Alberto S. Pappo;Shreyaskumar R. Patel;John Crowley;Denise K. Reinke.
Journal of Clinical Oncology (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: